SwiftPharma

Foundation date

04/02/2022

Sector

#Biotechnology - other

Subsector

Development of recombinant biologics using plants as mini-bioreactors. Our technology combines speed, agility, scalability, safety, and low-cost production completely animal-free

Upcoming events

Latest news

  • Bimekizumab Phase 3 data in hidradenitis suppurativa show clinically meaningful, deep and maintained response over 48 weeks

    Monday March 20th 2023

  • VIB launches Data Core to support life sciences research

    Thursday March 16th 2023

  • Aitia and UCB announce strategic drug discovery collaboration in Huntington's Disease

    Thursday March 16th 2023